Company: SXTPW
Filing Date: 2025-09-05
Form Type: 424B5
Source: 0001213900-25-085050
Chunk: 44

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-05
Form: 424B5
Chunk 44
---
other than the date on the front page of this prospectus supplement, regardless of the time of delivery of this prospectus supplement
or any sale of the securities offered hereby.

We file annual, quarterly, and other reports, proxy and information
statements, and other information with the Securities and Exchange Commission. The SEC maintains a website that contains reports, proxy
statements and other information regarding us. The address of the SEC website is www.sec.gov. We maintain a website at https://60degreespharma.com,
at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or
furnished to, the SEC. Information contained on our website is not incorporated into this prospectus supplement and you should not consider
information contained on our website to be part of this prospectus supplement.

<div align='center'>S-26

INFORMATION INCORPORATED BY REFERENCE</div>

The SEC allows us to “incorporate
by reference” information from other documents that we file with it, which means that we can disclose important information to
you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Information
in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus.
We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or
documents listed below that we filed with the SEC:

Notwithstanding the statements in the preceding
paragraphs, no document, report or exhibit (or portion of any of the foregoing) or any other information that we have “furnished”
to the SEC pursuant to the Exchange Act shall be incorporated by reference into this prospectus.

We also incorporate by reference into this prospectus
all documents (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are
related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after
the date of the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the registration
statement, or (ii) after the date of this prospectus but prior to the termination of the offering. These documents include periodic reports,
such as Annual Reports on Form 10-K, Quarterly Reports